Achieve Life Sciences
ACHV
63 hedge funds and large institutions have $42.3M invested in Achieve Life Sciences in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 20 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 65 → 63 (-2)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
40% less capital invested
Capital invested by funds: $70.9M → $42.3M (-$28.6M)
69% less call options, than puts
Call options by funds: $738K | Put options by funds: $2.35M
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.8M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$5.15M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$4.82M |
| 4 |
First Eagle Investment Management
New York
|
+$3.21M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.98M |
Top Sellers
ACHV Hedge Fund Activity: Q2 2014 in Review
63 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2014, worth a combined $42.3M — down 40% from $70.9M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ACHV and 18 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 21 added.
The largest buyer was Great Point Partners, opening a new position worth an estimated $11.8M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.04M.
- 63 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2014, down from 65 in Q1 2014.
- Funds reported $42.3M of Achieve Life Sciences stock for Q2 2014, down 40% quarter-over-quarter.
- 18 funds opened new Achieve Life Sciences positions in Q2 2014 and 20 closed out, a net change of -2 holders.
- The largest Achieve Life Sciences buyer in Q2 2014 was Great Point Partners, an estimated $11.8M added.
- The largest Achieve Life Sciences seller in Q2 2014 was BlackRock Fund Advisors, an estimated $2.04M sold.
Based on aggregated 13F filings for Q2 2014.